Article
Increased prevalence of the Taq I A1 allele of the dopamine receptor gene (DRD2) in obesity with comorbid substance use disorder: a preliminary report.
Pharmacogenetics - 1 Aug 1996
Blum K, Braverman E R, Wood R C, Gill J, Li C, Chen T J, Taub M, Montgomery A R, Sheridan P J, Cull J G
Abstract excerpt
In order to investigate the prevalence of the Taq I A1 allele of the dopamine receptor gene (DRD2) in obesity with and without comorbid substance use disorder, a total of 40 patients, from an outpatient neuropsychiatric clinic in Princeton, New Jersey, were genotyped for presence or absence of the Taq I DRD2 A1 allele. The primary inclusion criterion for 40 obese subjects was a body mass index (BMI) equal to or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.